297 related articles for article (PubMed ID: 25818668)
1. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
[TBL] [Abstract][Full Text] [Related]
2. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.
John M; Keller MJ; Fam EH; Cheshenko N; Hogarty K; Kasowitz A; Wallenstein S; Carlucci MJ; Tuyama AC; Lu W; Klotman ME; Lehrer RI; Herold BC
J Infect Dis; 2005 Nov; 192(10):1731-40. PubMed ID: 16235171
[TBL] [Abstract][Full Text] [Related]
3. The effects of reproductive hormones on the physical properties of cervicovaginal fluid.
Chappell CA; Rohan LC; Moncla BJ; Wang L; Meyn LA; Bunge K; Hillier SL
Am J Obstet Gynecol; 2014 Sep; 211(3):226.e1-7. PubMed ID: 24662718
[TBL] [Abstract][Full Text] [Related]
4. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
[TBL] [Abstract][Full Text] [Related]
5. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection.
Murphy K; Keller MJ; Anastos K; Sinclair S; Devlin JC; Shi Q; Hoover DR; Starkman B; McGillick J; Mullis C; Minkoff H; Dominguez-Bello MG; Herold BC
PLoS One; 2019; 14(4):e0216049. PubMed ID: 31026271
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of hormonal contraceptive use and cervical shedding of herpes simplex virus in human immunodeficiency virus type 1-seropositive women.
McClelland RS; Wang CC; Richardson BA; Corey L; Ashley RL; Mandaliya K; Ndinya-Achola J; Bwayo JJ; Kreiss JK
J Infect Dis; 2002 Jun; 185(12):1822-5. PubMed ID: 12085333
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
Thurman A; Chandra N; Schwartz JL; Brache V; Chen BA; Asin S; Rollenhagen C; Herold BC; Fichorova RN; Hillier SL; Weiner DH; Mauck C; Doncel GF
AIDS Res Hum Retroviruses; 2019 Sep; 35(9):853-864. PubMed ID: 30997816
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.
Thurman AR; Chandra N; Yousefieh N; Zalenskaya I; Kimble T; Asin S; Rollenhagen C; Anderson SM; Herold B; Mesquita PM; Richardson-Harman N; Cunningham T; Schwartz JL; Doncel GF
AIDS Res Hum Retroviruses; 2016 Jun; 32(6):547-60. PubMed ID: 26750085
[TBL] [Abstract][Full Text] [Related]
10. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
11. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
12. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
[TBL] [Abstract][Full Text] [Related]
13. Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.
Shust GF; Cho S; Kim M; Madan RP; Guzman EM; Pollack M; Epstein J; Cohen HW; Keller MJ; Herold BC
Am J Reprod Immunol; 2010 Feb; 63(2):110-9. PubMed ID: 20015330
[TBL] [Abstract][Full Text] [Related]
14. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation.
Ghanem KG; Shah N; Klein RS; Mayer KH; Sobel JD; Warren DL; Jamieson DJ; Duerr AC; Rompalo AM;
J Infect Dis; 2005 Feb; 191(3):358-66. PubMed ID: 15633094
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
Ghosh M; Fahey JV; Shen Z; Lahey T; Cu-Uvin S; Wu Z; Mayer K; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
PLoS One; 2010 Jun; 5(6):e11366. PubMed ID: 20614007
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV Status.
Ghosh M; Jais M; Delisle J; Younes N; Benyeogor I; Biswas R; Mohamed H; Daniels J; Wang C; Young M; Kassaye S
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):251-259. PubMed ID: 30618272
[TBL] [Abstract][Full Text] [Related]
17. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
Keller MJ; Zerhouni-Layachi B; Cheshenko N; John M; Hogarty K; Kasowitz A; Goldberg CL; Wallenstein S; Profy AT; Klotman ME; Herold BC
J Infect Dis; 2006 Jan; 193(1):27-35. PubMed ID: 16323128
[TBL] [Abstract][Full Text] [Related]
18. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women.
Thurman AR; Yousefieh N; Chandra N; Kimble T; Asin S; Rollenhagen C; Anderson SM; Herold BC; Freiermuth JL; Starkman BS; Mesquita PMM; Richardson-Harman N; Cunningham T; Hillier S; Rabe L; Schwartz JL; Doncel GF
AIDS Res Hum Retroviruses; 2017 Aug; 33(8):807-819. PubMed ID: 28398069
[TBL] [Abstract][Full Text] [Related]
20. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
